Search by Drug Name or NDC
NDC 00006-5028-01 VERQUVO 2.5 mg/1 Details
VERQUVO 2.5 mg/1
VERQUVO is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is VERICIGUAT.
MedlinePlus Drug Summary
Vericiguat is used to reduce the risk of death and need for hospitalization in certain adults with heart failure. Vericiguat is in a class of medications called soluble guanylate cyclase (sGC) stimulators. It works by relaxing the blood vessels in the lungs to allow blood to flow easily.
Related Packages: 00006-5028-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Vericiguat
Product Information
| NDC | 00006-5028 |
|---|---|
| Product ID | 0006-5028_9bdc3dc1-e1f4-435b-923a-86ab6d16cf15 |
| Associated GPIs | 40900085000321 |
| GCN Sequence Number | 081858 |
| GCN Sequence Number Description | vericiguat TABLET 2.5 MG ORAL |
| HIC3 | Z1Z |
| HIC3 Description | SOLUBLE GUANYLATE CYCLASE (SGC) STIMULATOR |
| GCN | 49095 |
| HICL Sequence Number | 047075 |
| HICL Sequence Number Description | VERICIGUAT |
| Brand/Generic | Brand |
| Proprietary Name | VERQUVO |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | vericiguat |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | VERICIGUAT |
| Labeler Name | Merck Sharp & Dohme LLC |
| Pharmaceutical Class | Guanylate Cyclase Stimulators [MoA], Soluble Guanylate Cyclase Stimulator [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA214377 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00006-5028-01 (00006502801)
| NDC Package Code | 0006-5028-01 |
|---|---|
| Billing NDC | 00006502801 |
| Package | 14 TABLET, FILM COATED in 1 BOTTLE (0006-5028-01) |
| Marketing Start Date | 2021-02-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 21.2822 |
| Pricing Unit | EA |
| Effective Date | 2024-01-06 |
| NDC Description | VERQUVO 2.5 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis